 | • レポートコード：B-GIR09F3460 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レタパムリンの世界市場について調べ、まとめました。種類別セグメントは、1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ）等、用途別セグメントは、病院、薬局等に区分しました。レタパムリンの世界市場概観、企業動向、企業別レタパムリンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レタパムリンの市場概観 ・レタパムリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レタパムリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・レタパムリンの世界市場規模 ・レタパムリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・レタパムリンのアメリカ市場規模推移 ・レタパムリンのカナダ市場規模推移 ・レタパムリンのメキシコ市場規模推移 ・レタパムリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レタパムリンのドイツ市場規模推移 ・レタパムリンのイギリス市場規模推移 ・レタパムリンのロシア市場規模推移 ・レタパムリンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レタパムリンの日本市場規模推移 ・レタパムリンの中国市場規模推移 ・レタパムリンの韓国市場規模推移 ・レタパムリンのインド市場規模推移 ・レタパムリンの東南アジア市場規模推移 ・レタパムリンの南米市場分析（ブラジル、アルゼンチン等） ・レタパムリンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レタパムリンの種類別分析/販売量、売上、市場シェア（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ）） ・レタパムリンの用途別分析/市場規模（病院、薬局） ・レタパムリンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レタパムリンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.
Scope of the Report:
The global Retapamulin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Retapamulin.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Retapamulin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Retapamulin market by product type and applications/end industries.
Market Segment by Companies, this report covers
Almirall
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
1% ointment(15-gram tubes)
1% ointment(30-gram tubes)
Market Segment by Applications, can be divided into
Hospital
Drug store
Table of Contents
1 Retapamulin Market Overview
1.1 Product Overview and Scope of Retapamulin
1.2 Classification of Retapamulin by Types
1.2.1 Global Retapamulin Revenue Comparison by Types (2019-2024)
1.2.2 Global Retapamulin Revenue Market Share by Types in 2018
1.2.3 1% ointment(15-gram tubes)
1.2.4 1% ointment(30-gram tubes)
1.3 Global Retapamulin Market by Application
1.3.1 Global Retapamulin Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Retapamulin Market by Regions
1.4.1 Global Retapamulin Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Retapamulin Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Retapamulin Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retapamulin Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Retapamulin Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retapamulin Status and Prospect (2014-2024)
1.5 Global Market Size of Retapamulin (2014-2024)
2 Manufacturers Profiles
2.1 Almirall
2.1.1 Business Overview
2.1.2 Retapamulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Almirall Retapamulin Revenue, Gross Margin and Market Share (2017-2018)
3 Global Retapamulin Market Competition, by Players
3.1 Global Retapamulin Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Retapamulin Players Market Share
3.2.2 Top 10 Retapamulin Players Market Share
3.3 Market Competition Trend
4 Global Retapamulin Market Size by Regions
4.1 Global Retapamulin Revenue and Market Share by Regions
4.2 North America Retapamulin Revenue and Growth Rate (2014-2019)
4.3 Europe Retapamulin Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Retapamulin Revenue and Growth Rate (2014-2019)
4.5 South America Retapamulin Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Retapamulin Revenue and Growth Rate (2014-2019)
5 North America Retapamulin Revenue by Countries
5.1 North America Retapamulin Revenue by Countries (2014-2019)
5.2 USA Retapamulin Revenue and Growth Rate (2014-2019)
5.3 Canada Retapamulin Revenue and Growth Rate (2014-2019)
5.4 Mexico Retapamulin Revenue and Growth Rate (2014-2019)
6 Europe Retapamulin Revenue by Countries
6.1 Europe Retapamulin Revenue by Countries (2014-2019)
6.2 Germany Retapamulin Revenue and Growth Rate (2014-2019)
6.3 UK Retapamulin Revenue and Growth Rate (2014-2019)
6.4 France Retapamulin Revenue and Growth Rate (2014-2019)
6.5 Russia Retapamulin Revenue and Growth Rate (2014-2019)
6.6 Italy Retapamulin Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Retapamulin Revenue by Countries
7.1 Asia-Pacific Retapamulin Revenue by Countries (2014-2019)
7.2 China Retapamulin Revenue and Growth Rate (2014-2019)
7.3 Japan Retapamulin Revenue and Growth Rate (2014-2019)
7.4 Korea Retapamulin Revenue and Growth Rate (2014-2019)
7.5 India Retapamulin Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Retapamulin Revenue and Growth Rate (2014-2019)
8 South America Retapamulin Revenue by Countries
8.1 South America Retapamulin Revenue by Countries (2014-2019)
8.2 Brazil Retapamulin Revenue and Growth Rate (2014-2019)
8.3 Argentina Retapamulin Revenue and Growth Rate (2014-2019)
8.4 Colombia Retapamulin Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Retapamulin by Countries
9.1 Middle East and Africa Retapamulin Revenue by Countries (2014-2019)
9.2 Saudi Arabia Retapamulin Revenue and Growth Rate (2014-2019)
9.3 UAE Retapamulin Revenue and Growth Rate (2014-2019)
9.4 Egypt Retapamulin Revenue and Growth Rate (2014-2019)
9.5 Nigeria Retapamulin Revenue and Growth Rate (2014-2019)
9.6 South Africa Retapamulin Revenue and Growth Rate (2014-2019)
10 Global Retapamulin Market Segment by Type
10.1 Global Retapamulin Revenue and Market Share by Type (2014-2019)
10.2 Global Retapamulin Market Forecast by Type (2019-2024)
10.3 1% ointment(15-gram tubes) Revenue Growth Rate (2014-2024)
10.4 1% ointment(30-gram tubes) Revenue Growth Rate (2014-2024)
11 Global Retapamulin Market Segment by Application
11.1 Global Retapamulin Revenue Market Share by Application (2014-2019)
11.2 Retapamulin Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Retapamulin Market Size Forecast (2019-2024)
12.1 Global Retapamulin Market Size Forecast (2019-2024)
12.2 Global Retapamulin Market Forecast by Regions (2019-2024)
12.3 North America Retapamulin Revenue Market Forecast (2019-2024)
12.4 Europe Retapamulin Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Retapamulin Revenue Market Forecast (2019-2024)
12.6 South America Retapamulin Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Retapamulin Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Retapamulin Picture
Table Product Specifications of Retapamulin
Table Global Retapamulin and Revenue (Million USD) Market Split by Product Type
Figure Global Retapamulin Revenue Market Share by Types in 2018
Figure 1% ointment(15-gram tubes) Picture
Figure 1% ointment(30-gram tubes) Picture
Table Global Retapamulin Revenue (Million USD) by Application (2014-2024)
Figure Retapamulin Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Retapamulin Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Retapamulin Revenue (Million USD) and Growth Rate (2014-2024)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Retapamulin Type and Applications
Table Almirall Retapamulin Revenue, Gross Margin and Market Share (2017-2018)
Table Global Retapamulin Revenue (Million USD) by Players (2014-2019)
Table Global Retapamulin Revenue Share by Players (2014-2019)
Figure Global Retapamulin Revenue Share by Players in 2017
Figure Global Retapamulin Revenue Share by Players in 2018
Figure Global Top 5 Players Retapamulin Revenue Market Share in 2018
Figure Global Top 10 Players Retapamulin Revenue Market Share in 2018
Figure Global Retapamulin Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Retapamulin Revenue (Million USD) by Regions (2014-2019)
Table Global Retapamulin Revenue Market Share by Regions (2014-2019)
Figure Global Retapamulin Revenue Market Share by Regions (2014-2019)
Figure Global Retapamulin Revenue Market Share by Regions in 2018
Figure North America Retapamulin Revenue and Growth Rate (2014-2019)
Figure Europe Retapamulin Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Retapamulin Revenue and Growth Rate (2014-2019)
Figure South America Retapamulin Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Retapamulin Revenue and Growth Rate (2014-2019)
Table North America Retapamulin Revenue by Countries (2014-2019)
Table North America Retapamulin Revenue Market Share by Countries (2014-2019)
Figure North America Retapamulin Revenue Market Share by Countries (2014-2019)
Figure North America Retapamulin Revenue Market Share by Countries in 2018
Figure USA Retapamulin Revenue and Growth Rate (2014-2019)
Figure Canada Retapamulin Revenue and Growth Rate (2014-2019)
Figure Mexico Retapamulin Revenue and Growth Rate (2014-2019)
Table Europe Retapamulin Revenue (Million USD) by Countries (2014-2019)
Figure Europe Retapamulin Revenue Market Share by Countries (2014-2019)
Figure Europe Retapamulin Revenue Market Share by Countries in 2018
Figure Germany Retapamulin Revenue and Growth Rate (2014-2019)
Figure UK Retapamulin Revenue and Growth Rate (2014-2019)
Figure France Retapamulin Revenue and Growth Rate (2014-2019)
Figure Russia Retapamulin Revenue and Growth Rate (2014-2019)
Figure Italy Retapamulin Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Retapamulin Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Retapamulin Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Retapamulin Revenue Market Share by Countries in 2018
Figure China Retapamulin Revenue and Growth Rate (2014-2019)
Figure Japan Retapamulin Revenue and Growth Rate (2014-2019)
Figure Korea Retapamulin Revenue and Growth Rate (2014-2019)
Figure India Retapamulin Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Retapamulin Revenue and Growth Rate (2014-2019)
Table South America Retapamulin Revenue by Countries (2014-2019)
Table South America Retapamulin Revenue Market Share by Countries (2014-2019)
Figure South America Retapamulin Revenue Market Share by Countries (2014-2019)
Figure South America Retapamulin Revenue Market Share by Countries in 2018
Figure Brazil Retapamulin Revenue and Growth Rate (2014-2019)
Figure Argentina Retapamulin Revenue and Growth Rate (2014-2019)
Figure Colombia Retapamulin Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Retapamulin Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Retapamulin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Retapamulin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Retapamulin Revenue Market Share by Countries in 2018
Figure Saudi Arabia Retapamulin Revenue and Growth Rate (2014-2019)
Figure UAE Retapamulin Revenue and Growth Rate (2014-2019)
Figure Egypt Retapamulin Revenue and Growth Rate (2014-2019)
Figure Nigeria Retapamulin Revenue and Growth Rate (2014-2019)
Figure South Africa Retapamulin Revenue and Growth Rate (2014-2019)
Table Global Retapamulin Revenue (Million USD) by Type (2014-2019)
Table Global Retapamulin Revenue Share by Type (2014-2019)
Figure Global Retapamulin Revenue Share by Type (2014-2019)
Figure Global Retapamulin Revenue Share by Type in 2019
Table Global Retapamulin Revenue Forecast by Type (2019-2024)
Figure Global Retapamulin Market Share Forecast by Type (2019-2024)
Figure Global 1% ointment(15-gram tubes) Revenue Growth Rate (2014-2019)
Figure Global 1% ointment(30-gram tubes) Revenue Growth Rate (2014-2019)
Table Global Retapamulin Revenue by Application (2014-2019)
Table Global Retapamulin Revenue Share by Application (2014-2019)
Figure Global Retapamulin Revenue Share by Application (2014-2019)
Figure Global Retapamulin Revenue Share by Application in 2019
Table Global Retapamulin Revenue Forecast by Application (2019-2024)
Figure Global Retapamulin Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Retapamulin Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Retapamulin Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Retapamulin Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Retapamulin Revenue Market Forecast (2019-2024)
Figure Europe Retapamulin Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Retapamulin Revenue Market Forecast (2019-2024)
Figure South America Retapamulin Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Retapamulin Revenue Market Forecast (2019-2024)
世界のグラム陽性菌感染症薬市場予測（～2024年）：企業別、地域別、種類・用途別 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans. Scope of the Report: The global Gram-positive Bacterial Infection Drugs market is valued at xx million USD in 2018 and is expected to re…- 病院治療型グラム陰性感染症市場：世界及び中国市場分析・予測（～2024年） Hospital Treated Gram Negative Infections Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hospital Treated Gram Negative Infections industry with a focus on the Chinese market. The report provides key statistics on the market …
- 軟膏アジテーター市場：世界及び中国市場分析・予測（～2024年） Ointment Agitator Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ointment Agitator industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ointment Agitator manufacturers an…
- 世界の乳化軟膏市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Emulsifying Ointment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Emulsifying Ointme…
- 世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…